...
首页> 外文期刊>Plastic and reconstructive surgery >The Impact of Mastopexy on Brassiere Cup Size
【24h】

The Impact of Mastopexy on Brassiere Cup Size

机译:Mastopexy对胸罩杯尺寸的影响

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Surgeon observation suggested that mastopexy alone resulted in decreased cup size. The purpose of this investigation was to assess change in cup size in women undergoing mastopexy alone.Methods: A retrospective review of a single surgeon's experience from February of 2002 to May of 2011 was completed. Patients underwent mastopexy alone (specimen weight < 150 g per side). Exclusion criteria were prior breast augmentation, implant removal at time of mastopexy, combination breast augmentation-mastopexy, and incomplete follow-up. Patients were surveyed by telephone regarding preopcrative and postoperative cup size, changes in bra manufacturer, hormone status, and weight gain/loss, and data were analyzed.Results: Sixty-one patients met inclusion criteria, and 20 completed the survey. Their average age was 46.6 years (range, 35 to 76 years) and average body mass index was 22.8 kg/rn2 (range, 18.2 to 26.4 kgr). Eighty percent (n = 16) had grade II ptosis and 20 percent (n = 4) had grade 111 ptosis preoperatively. Average specimen weight per breast was 57.8 g (range, 4 to .149 g). Patients reported an average decrease in cup size of 0.90 cup sizes (range, -2 to +3 cup sizes). Excluding one patient who reported an increase, an average decrease of 1.05 cup sizes (range, 0 to 3 cup sizes) was seen. No patients reported changing bra manufacturer.Conclusions: Mastopexy alone results in an average decrease in one brassiere cup size. This is important for preoperative counseling, because patients should recognize that their actual cup size is smaller than the brassiere they wear, which will be reflected postoperatively despite a relatively stable volume.
机译:背景:外科医生的观察表明,单用马托吡昔酮可减少杯的大小。这项研究的目的是评估单用接受马普托昔单抗治疗的妇女的杯型变化。方法:回顾性回顾了2002年2月至2011年5月的一位外科医生的经历。患者仅接受马托吡昔酮治疗(每侧标本重量<150 g)。排除标准为既往隆胸,误用马托吡昔时去除植入物,联合隆胸-乳突和不完整的随访。通过电话调查患者的术前和术后杯大小,胸罩制造商的变化,激素状态以及体重增加/减少,并分析数据。结果:61名患者符合入选标准,其中20名完成了调查。他们的平均年龄为46.6岁(范围为35至76岁),平均体重指数为22.8 kg / rn2(范围为18.2至26.4 kg / nr)。术前有百分之八十(n = 16)的II级上睑下垂,百分之二十(n = 4)的患者有111级上垂。每个乳房的平均标本重量为57.8 g(范围为4到.149 g)。患者报告的杯大小平均减少了0.90杯大小(范围为-2到+3杯大小)。除报告增加的一名患者外,观察到平均减少了1.05杯大小(范围为0至3杯大小)。没有患者报告更换胸罩制造商。结论:单用马斯托吡昔酮可以平均减少一个胸罩杯的尺寸。这对于术前咨询很重要,因为患者应认识到他们的实际罩杯尺寸小于他们所穿的胸罩,尽管体积相对稳定,这仍会在术后反映出来。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号